跳至主要内容
临床试验/JPRN-UMIN000003255
JPRN-UMIN000003255尚未招募未知

Clinical study using denderitic cell vaccinations for cancer patients - Clinical study using denderitic cell vaccinations for cancer patients

Matsumoto Dental University0 个研究点目标入组 250 人开始时间: 2010年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Pregnant or lactating women 2) &#8805;100 IU/l ALT or AST before the start of therapy 3) <50,000 platelet count 4) Allergy to penicillin or picibanil 5) Patients judged ineligible for the therapy by an attending physician 6) Juveniles 7) Adults with impaired judgment

研究者

相似试验

招募中
不适用
Clinical trial evaluating dendritic cell vaccination as an adjuvant immunotherapy in patients with pancreatic cancerPancreatic cancer
JPRN-UMIN000009994Yokohama City University, Gastroenterological Surgery20
已完成
不适用
Clinical study of dendritic cell vaccine combined with transarterial embolization for patients with hepatocellular carcinomahepatocellular carcinoma
JPRN-UMIN000012702Faculty of Medical Sciences, University of Fukui3
招募中
不适用
A pilot study of dendritic cell vaccination for stage IV melanoma following combination lymphodepleting chemotherapy.Stage IV MelanomaCancer - Malignant melanoma
ACTRN12608000174381niversity of Queensland20
撤回
1 期
Phase I trial of dendritic cell vaccination and celecoxib with postoperative radiotherapy and temozolomide for treatment of malignant glioma.Malignant gliomaCancer - Brain
ACTRN12609000736246Queensland Institute of Medical Research10
进行中(未招募)
1 期
Complementary vaccination with dendritic cells pulsed with autologous tumor lysate in resected stage III and IV melanoma patients: a phase II randomized trial (ACDC adjuvant Trial)resected stage III and IV melanomaMedDRA version: 20.0Level: PTClassification code 10025671Term: Malignant melanoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10025670Term: Malignant melanoma stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2014-005123-27-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS120